Ankylosing Spondylitis
Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPod, November 2026
Ankylosing spondylitis (AS) is a long-term inflammatory disease that mainly affects the spine and the joints at the base of the spine. Estimates range from 0.1 to 0.5 per cent of people to about 1 in 200, depending on the region and how it is counted. The main symptoms are back pain and stiffness that build slowly, often easing with exercise and not with rest, along with tiredness. Anti-inflammatory medicines ease pain and stiffness, and exercise helps keep your spine moving. Other medicines are used when these aren't enough.
What is it?
Ankylosing spondylitis (AS) is a long-term inflammatory disease. It mainly affects the spine and the sacroiliac joints (the joints where the base of your spine meets your pelvis). It causes back pain, stiffness and tiredness, and other joints, tendons and ligaments can be involved too.
Over time, inflammation in the spine can lead to new bone growth. In some people, parts of the spine fuse together and lose flexibility.
AS is one form of axial spondyloarthritis (a group of inflammatory arthritis conditions that mainly affect the spine). In AS, damage to the sacroiliac joints shows up on X-ray. In the non-radiographic form, it does not, although the two share several features. People usually have back pain for several years before changes appear on X-ray.
AS can also cause enthesitis, which is inflammation where a tendon or ligament attaches to bone.
Who does it affect?
Estimates of how common AS is vary with region, ethnicity and how it is defined. Figures include 0.1 to 0.5 per cent of the population, and about 1 in 200 people. Across continents, the average runs from 7.4 per 10,000 people in Africa to 31.9 per 10,000 in North America. Rates are thought to follow how common the HLA-B27 gene variant is in the local population.
AS is reported to affect men more often than women, roughly 2 to 1, although this varies a lot between studies. Most of what is known comes from adults.
Signs and symptoms
AS usually starts slowly. Back pain and stiffness build up over weeks or months and last longer than three months. They often begin before the age of 45.
The pain has a recognisable pattern. It tends to ease with exercise and not with rest. It may wake you in the second half of the night, and morning stiffness lasts more than 30 minutes before wearing off with activity. Some people have buttock pain that switches from side to side. Being able to describe when it began, whether it wakes you, how long the stiffness lasts and what makes it better or worse helps give a clear picture.
Other signs include pain and swelling in other joints, enthesitis, and extreme tiredness. Symptoms can flare and settle. AS can also involve other parts of the body, including inflammation inside the eye (uveitis), the skin condition psoriasis, and inflammatory bowel disease (inflammation of the gut). Uveitis is more common in people who carry HLA-B27. Psoriasis and bowel disease are more common in people with AS who do not.
Some signs can point to something more serious. A painful or red eye, or vision changes such as blurred vision, floaters, partial loss of sight or sensitivity to light, can mean uveitis. Diarrhoea lasting more than two weeks, or bloody or slimy stools, can mean inflammatory bowel disease. Back pain with features of cauda equina syndrome (pressure on the nerves at the base of the spine), a spinal fracture, cancer or a spinal infection can look like, or complicate, AS-type back pain.
A swollen, 'sausage' finger or toe (dactylitis), or enthesitis that lasts or appears in several places without an obvious mechanical cause, can point to peripheral spondyloarthritis (spondyloarthritis affecting joints and tendon attachments outside the spine).
Early on, AS is easy to mistake for common back trouble, or for tendon and joint problems that are unrelated to it.
What causes it?
The exact cause isn't known. AS is thought to be autoimmune (the immune system acts against the body's own tissues). It involves both genes and environment, and more than 90 per cent of the risk of developing it is thought to be genetic.
The gene variant HLA-B27 is the strongest genetic risk factor. About 85 per cent of people with AS carry it, but only 1 to 5 per cent of people who carry it develop AS. The gene is neither needed for AS nor enough on its own, so a positive test is not a diagnosis or a prediction. Other genes, called ERAP1 and IL23R, also add to the risk.
The gut may also play a part. Up to 70 per cent of people with AS have inflammation in the gut that causes no symptoms. This suggests the disease may start there, but that is still an idea, not a proven fact. Current smoking also seems to raise the risk of AS. No single environmental trigger has been identified.
How is it diagnosed?
AS can be hard to diagnose. It develops slowly and there is no single test that confirms it, so confirming it can take years. Your doctor puts together your history, an examination, blood tests, an HLA-B27 test and imaging.
A key feature that separates AS from the non-radiographic form is damage to the sacroiliac joints on X-ray. This can take years to appear.
Blood tests that show no inflammation do not rule AS out, and more tests may be needed. An HLA-B27 test cannot confirm or exclude AS by itself. It is not used to screen people without symptoms or as a routine test.
Back pain that lasts over three months and began before age 45, with several other typical features, is a pattern that can lead to referral to a rheumatologist (an arthritis specialist). With fewer features, an HLA-B27 test may be used first.
Treatment
Care usually combines medicines, regular exercise and, for people who smoke, quitting.
Anti-inflammatory medicines
NSAIDs (non-steroidal anti-inflammatory drugs) have the strongest support as a first treatment. After six weeks they work better than a dummy treatment (placebo) for pain, disease activity and everyday function. Pain scores on a 100 mm scale were 16.5 points lower. Whether they also slow damage to the spine is less certain.
NSAIDs carry their own risks. Indomethacin has been linked to more side effects than other NSAIDs, although that did not hold up in every check. Celecoxib has been linked to a modest rise in cardiovascular (heart and blood vessel) risk, and the choice of medicine takes other health conditions into account.
Looking after it at home
- Regular low-impact exercise, such as water exercise, helps keep muscles strong and joints mobile and flexible.
- Quitting smoking is advised, because smoking is linked to more severe AS and a weaker response to treatment.
- Back exercises may not suit everyone, particularly people who have a health problem or a recent injury, or who are unsure whether they suit them. Pain or feeling unwell during exercise is a reason to stop.
Other options
When first treatments aren't enough, TNF inhibitors are used. These block TNF-alpha, a substance that is higher in people with AS. People with AS respond well to this kind of treatment. Starting them in early AS (under 10 years) is linked to greater benefit, and smoking is linked to a poorer response.
Etanercept and secukinumab have been linked to a higher risk of uveitis than the monoclonal TNF inhibitors, so eye symptoms that start during treatment are taken seriously. Adding an NSAID to a TNF inhibitor was tolerated about as well as a TNF inhibitor alone, though more people stopped taking the combination.
Recovery
The course of AS varies from person to person. Several things are linked to faster changes on X-ray: being male, carrying HLA-B27, changes on X-ray at the start, a long time with the disease, a high CRP (a blood marker of inflammation), high disease activity, smoking and alcohol.
Smoking is also linked to more severe disease and a weaker response to treatment. Starting TNF inhibitors in early AS is linked to greater benefit. How often flares happen, and how long calm spells last, isn't clear yet.
Preventing it
People at higher risk, such as those with a family history of AS or the HLA-B27 gene variant, are advised to avoid smoking, e-cigarettes included.
If you already have AS, regular exercise helps preserve movement and flexibility. Alcohol has been linked to faster changes on X-ray, so it can be worth raising as part of your overall care.
Frequently asked questions
Does ankylosing spondylitis always lead to a fused spine?
No. Over time, inflammation can cause new bone growth, and in some people parts of the spine fuse and lose flexibility. This happens slowly, as the inflamed joint spaces gradually heal and turn to bone, and bone bridges can link neighbouring vertebrae (the small bones of the spine).
Can ankylosing spondylitis affect the heel or Achilles tendon?
Enthesitis (inflammation where tendons or ligaments attach to bone) is a typical feature of AS. Plantar fasciitis and Achilles tendonitis are both listed types of enthesitis. Mechanical stress at these attachment points may also help trigger enthesitis.
Why does it take so long to get diagnosed?
For many people the average is 8 to 9 years. Early symptoms look like common back problems, and spondyloarthritis is often mistaken for chronic back pain or for unrelated tendonitis and joint problems. Many people also put up with the pain for some time before seeking help.
Further reading
This is general information, not medical advice. For advice about your own situation, see your health professional. For urgent advice, call your local health advice line or emergency number, or go to an emergency department.